Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP186428.RA0n0SXSOIlKRihNjEf4DfgNbGwYw9-jEO-UPavJuDC5s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP186428.RA0n0SXSOIlKRihNjEf4DfgNbGwYw9-jEO-UPavJuDC5s130_assertion type Assertion NP186428.RA0n0SXSOIlKRihNjEf4DfgNbGwYw9-jEO-UPavJuDC5s130_head.
- NP186428.RA0n0SXSOIlKRihNjEf4DfgNbGwYw9-jEO-UPavJuDC5s130_assertion description "[ PTCs with METE without NMP have an extremely low recurrence rate in contrast to tumors with gross ETE. (ii) High mitotic activity and/or tumor necrosis confers worse DSS even in patients stratified for gross ETE in trachea/esophagus. (iii) BRAF positivit]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP186428.RA0n0SXSOIlKRihNjEf4DfgNbGwYw9-jEO-UPavJuDC5s130_provenance.
- NP186428.RA0n0SXSOIlKRihNjEf4DfgNbGwYw9-jEO-UPavJuDC5s130_assertion evidence source_evidence_literature NP186428.RA0n0SXSOIlKRihNjEf4DfgNbGwYw9-jEO-UPavJuDC5s130_provenance.
- NP186428.RA0n0SXSOIlKRihNjEf4DfgNbGwYw9-jEO-UPavJuDC5s130_assertion SIO_000772 20860430 NP186428.RA0n0SXSOIlKRihNjEf4DfgNbGwYw9-jEO-UPavJuDC5s130_provenance.
- NP186428.RA0n0SXSOIlKRihNjEf4DfgNbGwYw9-jEO-UPavJuDC5s130_assertion wasDerivedFrom gad-20150221 NP186428.RA0n0SXSOIlKRihNjEf4DfgNbGwYw9-jEO-UPavJuDC5s130_provenance.
- NP186428.RA0n0SXSOIlKRihNjEf4DfgNbGwYw9-jEO-UPavJuDC5s130_assertion wasGeneratedBy ECO_0000203 NP186428.RA0n0SXSOIlKRihNjEf4DfgNbGwYw9-jEO-UPavJuDC5s130_provenance.